BGL’s Head of Healthcare & Life Sciences John Riddle was quoted in a recent article published by Axios entitled, “Private equity keeping faith with pharma services.”
The article discusses that although private equity healthcare M&A remained flat last quarter, optimism around pharma services is growing due to improved biotech funding and increased outsourcing by large drug companies. John says he expects pharma services dealmaking to pick up in the latter half of 2024.
For all of John’s insights, read the full article on the Axios website (subscription required).